{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:11:15Z","timestamp":1777871475712,"version":"3.51.4"},"reference-count":17,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2023,5,17]]},"abstract":"<jats:p>ACC007 is a new-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) with favorable pharmacokinetic and safety profiles. NNRTIs are typically administered in combination with two nucleoside reverse transcriptase inhibitors as first-line recommended regimens in several guidelines.<\/jats:p>","DOI":"10.1128\/aac.01219-22","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T14:00:19Z","timestamp":1682949619000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["No Meaningful Drug-Drug Interactions Are Associated with the Coadministration of ACC007, Lamivudine, and Tenofovir Disoproxil Fumarate"],"prefix":"10.1128","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6695-5641","authenticated-orcid":true,"given":"Xiaohua","family":"Hao","sequence":"first","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ni","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wu","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoshun","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Tian","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xiao","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangmei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","first-page":"1106","article-title":"Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2021 edition)","volume":"60","author":"AIDS, Hepatitis C Professional Group SoIDCMA, Chinese Center for Disease Control and Prevention","year":"2021","unstructured":"AIDS, Hepatitis C Professional Group SoIDCMA, Chinese Center for Disease Control and Prevention. 2021. Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2021 edition). Zhonghua Nei Ke Za Zhi 60:1106\u20131128. (In Chinese).","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31311-4"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.03.004"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2018.1474202"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000137006.70999.d3"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13268"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2019.1604685"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570162X18666200620211922"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S65596"},{"key":"e_1_3_3_11_2","unstructured":"World Health Organization. 2021. Consolidated guidelines on HIV prevention testing treatment service delivery and monitoring: recommendations for a public health approach. https:\/\/pubmed.ncbi.nlm.nih.gov\/34370423\/."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1383\/medc.31.8.16.27685"},{"key":"e_1_3_3_13_2","unstructured":"Genelex Labs LLC. CYP2C19 Genotyping. https:\/\/www.genelex.com\/test-menu\/cyp2c19\/."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3324"},{"key":"e_1_3_3_15_2","volume-title":"3rd IAS conference on HIV pathogenesis, treatment and prevention","author":"Hoetelmans R","year":"2005","unstructured":"Hoetelmans R, Kestens D, Stevens MC, Peeters M, Williams PE, Bastiaanse L. 2005. Pharmacokinetic interaction between TMC278, an investigational non-nucleoside reverse transcriptase inhibitor, and tenofovir in healthy volunteers. 3rd IAS conference on HIV pathogenesis, treatment and prevention, abstr WePe33C15. International AIDS Society, Geneva, Switzerland."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2254"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199936010-00004"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.12793\/tcp.2021.29.e4"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01219-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01219-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T13:06:12Z","timestamp":1684328772000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01219-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,17]]}},"alternative-id":["10.1128\/aac.01219-22"],"URL":"https:\/\/doi.org\/10.1128\/aac.01219-22","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"assertion":[{"value":"2022-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01219-22"}}